working in partnership with Roche on C. diff as well as inflammatory bowel disease (IBD), as well as Vedanta, Seres Therapeutics, Evelo, Finch Therapeutics and uBiome. Vedanta has a longstanding ...
Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...
This groundbreaking innovation offers a safe, non-opioid-based solution for conditions such as irritable bowel syndrome (IBS) and ...
Inflammatory bowel disease is a chronic condition of unknown origin characterized by severe inflammation and mucosal destruction in the intestine. There are two main forms: Crohn s disease ...
An antibiotic stewardship intervention at urgent care centers was associated with lower rates of inappropriate prescribing for bronchitis and viral upper respiratory infections, although active ...
Space can be a wondrous place, and we've got the pictures to prove it! Take a look at our favorite space pictures here, and if you're wondering what happened to today in space history don't miss ...
IIb and III); and C: requires evidence from expert committee reports or opinions or clinical experience of respected authorities in the absence of directly applicable clinical studies of good quality ...
Tinidazole is a structural analog of metronidazole and has been available in Europe for more than 2 decades. After activation, its toxic intermediates covalently bind to DNA, resulting in DNA ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果